LOC144438 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.742960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.916400E-01
Normal-vs-Stage2
1.486190E-01
Normal-vs-Stage3
1.315780E-01
Normal-vs-Stage4
5.293800E-01
Stage1-vs-Stage2
1.744020E-01
Stage1-vs-Stage3
6.943900E-02
Stage1-vs-Stage4
3.638600E-01
Stage2-vs-Stage3
8.899600E-02
Stage2-vs-Stage4
7.970200E-01
Stage3-vs-Stage4
1.860460E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.944650E-01
Normal-vs-AfricanAmerican
5.176800E-01
Normal-vs-Asian
1.201620E-01
Caucasian-vs-AfricanAmerican
7.067000E-01
Caucasian-vs-Asian
5.851700E-02
AfricanAmerican-vs-Asian
1.819450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.447200E-01
Normal-vs-Female
1.282980E-01
Male-vs-Female
3.217000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.643400E-01
Normal-vs-Age(41-60Yrs)
7.259200E-01
Normal-vs-Age(61-80Yrs)
9.883800E-02
Normal-vs-Age(81-100Yrs)
1.868030E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.100800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.202380E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.920640E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.819700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.090000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.162200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.112000E-02
Normal-vs-Daily Drinker
1.043560E-01
Normal-vs-Weekly Drinker
7.605900E-02
Normal-vs-Occasional Drinker
4.698800E-01
Normal-vs-Social Drinker
3.990600E-01
Non Drinker-vs-Daily Drinker
7.366400E-01
Non Drinker-vs-Weekly Drinker
5.474400E-01
Non Drinker-vs-Occasional Drinker
2.252100E-02
Non Drinker-vs-Social Drinker
1.275430E-01
Daily Drinker-vs-Weekly Drinker
3.917800E-01
Daily Drinker-vs-Occasional Drinker
5.741900E-02
Daily Drinker-vs-Social Drinker
2.333200E-01
Weekly Drinker-vs-Occasional Drinker
1.676070E-02
Weekly Drinker-vs-Social Drinker
8.746200E-02
Occasional Drinker-vs-Social Drinker
6.280400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.046300E-02
Normal-vs-Grade 2
2.447600E-02
Normal-vs-Grade 3
1.921540E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.263000E-01
Grade 1-vs-Grade 3
4.304000E-01
Grade 1-vs-Grade 4
7.046300E-02
Grade 2-vs-Grade 3
9.621400E-01
Grade 2-vs-Grade 4
2.447600E-02
Grade 3-vs-Grade 4
1.921540E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.332800E-01
Normal-vs-NonDiabetic
1.695820E-01
Diabetic-vs-NonDiabetic
3.561000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.399600E-01
Normal-vs-NoPancreatitis
1.567970E-01
Pancreatitis-vs-NoPancreatitis
6.263200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.959790E-01
Normal-vs-N1
1.622230E-01
N0-vs-N1
8.167000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.322000E-01
Normal-vs-TP53-NonMutant
4.859200E-01
TP53-Mutant-vs-TP53-NonMutant
1.999550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
